Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Six-Month Follow-Up after Vaccination with BNT162b2: SARS-CoV-2 Antigen-Specific Cellular and Humoral Immune Responses in Hemodialysis Patients and Kidney Transplant Recipients.
Boedecker-Lips SC, Lautem A, Runkel S, Klimpke P, Kraus D, Keil P, Holtz S, Tomalla V, Marczynski P, Boedecker CB, Galle PR, Koch M, Weinmann-Menke J. Boedecker-Lips SC, et al. Among authors: lautem a. Pathogens. 2022 Jan 5;11(1):67. doi: 10.3390/pathogens11010067. Pathogens. 2022. PMID: 35056015 Free PMC article.
Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.
Heise M, Lautem A, Knapstein J, Schattenberg JM, Hoppe-Lotichius M, Foltys D, Weiler N, Zimmermann A, Schad A, Gründemann D, Otto G, Galle PR, Schuchmann M, Zimmermann T. Heise M, et al. Among authors: lautem a. BMC Cancer. 2012 Mar 22;12:109. doi: 10.1186/1471-2407-12-109. BMC Cancer. 2012. PMID: 22439694 Free PMC article.
Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
Lautem A, Heise M, Gräsel A, Hoppe-Lotichius M, Weiler N, Foltys D, Knapstein J, Schattenberg JM, Schad A, Zimmermann A, Otto G, Lang H, Galle PR, Schuchmann M, Zimmermann T. Lautem A, et al. Int J Oncol. 2013 Apr;42(4):1297-304. doi: 10.3892/ijo.2013.1840. Epub 2013 Feb 22. Int J Oncol. 2013. PMID: 23440379
Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis.
Vollmar J, Lautem A, Closs E, Schuppan D, Kim YO, Grimm D, Marquardt JU, Fuchs P, Straub BK, Schad A, Gründemann D, Schattenberg JM, Gehrke N, Wörns MA, Baumgart J, Galle PR, Zimmermann T. Vollmar J, et al. Among authors: lautem a. Oncotarget. 2017 Dec 18;8(70):115667-115680. doi: 10.18632/oncotarget.23372. eCollection 2017 Dec 29. Oncotarget. 2017. PMID: 29383190 Free PMC article.
Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.
Zimmermann T, Otto C, Hoppe-Lotichius M, Biesterfeld S, Lautem A, Knaak M, Zimmermann A, Barreiros AP, Heise M, Schattenberg JM, Sprinzl MF, Galle PR, Otto G, Schuchmann M. Zimmermann T, et al. Among authors: lautem a. Transplant Proc. 2009 Jul-Aug;41(6):2549-56. doi: 10.1016/j.transproceed.2009.06.120. Transplant Proc. 2009. PMID: 19715972
The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation.
Zimmermann T, Hoppe-Lotichius M, Körner A, Lautem A, Heise M, Foltys D, Weiler N, Biesterfeld S, Schmidtmann I, Galle PR, Otto G, Schuchmann M. Zimmermann T, et al. Among authors: lautem a. Transpl Int. 2011 Nov;24(11):1059-67. doi: 10.1111/j.1432-2277.2011.01305.x. Epub 2011 Jul 28. Transpl Int. 2011. PMID: 21797939 Free article.
15 results